Last update June 23, 2022
Limited compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
N05AA02 is Levomepromazine in ATC Code/s.
Is written in other languages:N05AA02 is also known as
N05AA02 belongs to these groups or families:
Main tradenames from several countries containing N05AA02 in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 50 - 60 | % |
Molecular weight | 329 | daltons |
VD | 14 - 42 | l/Kg |
pKa | 9.19 | - |
Tmax | 1 - 3 | hours |
T½ | 15 - 30 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Levomepromazine is a typical, first generation antipsychotic, phenothiazine, with pharmacological activity similar to that of both chlorpromazine and promethazine. Indicated in the treatment of schizophrenia and psychosis. It is also useful in the treatment of pain, nausea and vomiting of central origin and insomnia. Oral or intramuscular administration in 2 to 4 daily doses.
Since the last update we have not found any published data on its excretion in breast milk.
Given their powerful sedative effects, other drugs are preferable during breastfeeding.
Somnolence and adequate feeding of the infant should be monitored.
Because it can cause sedation and drowsiness, it is not recommended to share a bed (co-sleeping, bed-sharing) with the baby if this medication is being taken, due to increased risk of asphyxia or sudden infant deat
See below the information of this related product: